H. El Lahlou et al. / Phytochemistry 52 (1999) 623±629
627
2
6.8 min were collected to give 3a (2.8 mg) and 4a
0.26 (3H, s,H-26), 0.85 (3H, d, J = 6.4 Hz, H-29), 0.96
(3H, d, J = 6.7 Hz, H-30), 1.11 (3H, s, H-23), 1.18
(
0.7 mg), respectively.
(
3H, s, H-27), 1.25±1.78 (18H, m, H-5, 6, 7, 9, 11, 15,
3
.6. 1b,2a,3a,24-Tetrahydroxyurs-12-en-28-oic acid (1)
16, 19, 20, 21, 22), 1.93, 1.98, 2.09 and 2.16 (3H each,
s, 4 Â OAc), 3.60 (3H, s, 17-COOMe), 4.07 (1H, d,
J = 11.6 Hz, H-24a), 4.25 (1H, d, J = 11.6 Hz, H-
24b), 5.15 (2H, bs, H-2 and H-1), 5.36 (2H, br s, H-12
and H-3).
1
H NMR (500 MHz, CD OD): d 0.87 (3H, s, H-26),
3
0.92 (3H, d, J = 6.4 Hz, H-29), 1.01 (3H, d,
J = 7.5 Hz, H-30), 1.02 (3H, s, H-25), 1.10 (3H, s, H-
2
9
3), 1.17 (3H, s, H-27), 1.19±2.00 (17H, m, H-5, 6, 7,
, 11a, 15, 16, 19, 20, 21, 22), 2.23 (1H, d, J = 9.6 Hz,
3.9. 1b,2a,3a,24-Tetrahydroxyolean-12-en-28-oic acid
(2)
H-18), 2.50 (1H, m, H-11b), 3.44 (1H, d, J = 11.4 Hz,
H-24a), 3.50 (1H, d, J = 9.6 Hz, H-1), 3.65 (1H, dd,
J = 9.6 and 3.1 Hz, H-2), 3.70 (1H, d, J = 11.4 Hz,
H24b), 3.85 (1H, d, J = 3.1 Hz, H-3), 5.12 (1H, t,
1
H NMR (300 MHz, CD OD): d 0.84 (3H, s, H-26),
3
0.93 (3H, s, H-29), 0.98 (3H, s, H-30), 1.01 (3H, s, H-
23), 1.21 (3H, s, H-27), 1.32-2.13 (17H, m, H-5, 6, 7, 9,
11a, 15, 16, 19, 21, 22), 2.88 (1H, dd, J = 9.0 and
3.5 Hz, H-18), 2.46 (1H, m, H-11b), 3.44 (1H, d,
J = 11.4 Hz, H-24a), 3.48 (1H, d, J = 9.7 Hz, H-1),
3.64 (1H, dd, J = 9.7 and 3.1 Hz, H-2), 3.70 (1H, d,
J = 11.4 Hz, H-24b), 3.85 (1H, d, J = 3.1 Hz, H-3),
13
J = 3.3 Hz, H-12); C NMR (125 MHz, CD OD): d
3
79.4 (C-1), 69.7 (C-2) 73.2 (C-3), 42.9 (C-4), 47.6 (C-
5), 16.2 (C-6), 32.8 (C-7), 39.5 (C-8), 42.3 (C-9), 38.6
(
(
C-10), 26.1 (C-11), 125.6 (C-12), 137.0 (C-13), 47.9
C-14), 27.4 (C-15), 36.3 (C-16), 41.2 (C-17), 52.5 (C-
1
2
8), 30.0 (C-19), 23.5 (C-20), 27.4 (C-21), 38.5 (C-22),
1.1 (C-23), 63.7 (C-24), 11.6 (C-25), 15.7 (C-26), 22.1
13
5.26 (1H, t, J = 3.2 Hz, H-12); C NMR (75 MHz,
CD OD): d 79.2 (C-1), 69.7 (C-2), 73.2 (C-3), 42.9 (C-
(
C-27), 178.0 (C-28), 19.8 (C-29), 17.4 (C-30). The dis-
3
tance between 1b-OH and 11b-H of 1 was measured
after minimisation of its energy by an MNDO method
of CS Chem3D Pro version 3.5.1 (Cambridge Soft
Corporation, Massachusetts, USA).
4), 47.8 (C-5), 22.3 (C-6), 33.2 (C-7), 39.2 (C-8), 42.3
(C-9), 31.7 (C-10), 26.2 (C-11), 122.2 (C-12), 142.7 (C-
13), 47.6 (C-14), 27.0 (C-15), 32.0 (C-16), 40.8 (C-17),
52.5 (C-18), 24.5 (C-19), 32.4 (C-20), 28.8 (C-21), 29.7
(C-22), 21.1 (C-23), 63.7 (C-24), 11.4 (C-25), 16.1 (C-
26), 12.1 (C-27), 178.0 (C-28), 17.5 (C-29), 16.1 (C-30).
3.7. Methylation of compound 1
Compound 1 (1.2 mg) was dissolved in 0.8 ml of
MeOH, and treated with an ether soln of CH N at
3.10. Methylation of compound 2
2
2
room temp. for 2 h. After evaporation of the solvent,
�
Compound 2 (1.0 mg) was methylated by the same
1
1
.2 mg of methyl ester 1a was obtained. IR nmax cm
:
400, 2700, 1750, 1600, 1450; EIMS (probe) 70 eV, m/
method as that for 1 to give a methyl ester 2a. IR n
max
cm : 3300, 1730, 1600, 1100; EIMS (probe) 70 eV, m/
�
1
3
z (rel. int.): 518 [M] (7), 500 (50), 262 (92), 203 (100),
+
+
z (rel. int.): 518 [M] (10), 500 (20), 262 (62), 203
(100), 189 (36), 133 (21); HR-EIMS (probe) 70 eV:
+
89 (35), 133 (47); HR±EIMS (probe) 70 eV: [M] at
1
m/z 518.3605 (C H O requires 518.3607); H NMR
1
+
[M] at m/z 518.3548 (C H O requires 518.3607);
3
1
50
6
31 50
6
1
(
J = 7.2 Hz, H-29), 0.88 (3H, s, H-23 and H-26), 0.97
300 MHz, CDCl ): d 0.73 (3H, s, H-25), 0.87 (3H, d,
H NMR (300 MHz, CDCl ); d 0.70 (3H, s, H-26),
3
3
0.85 (3H, s, H-29), 0.89 (3H, s, H-30), 0.93 (3H, s, H-
25), 0.97 (3H, s, H-23), 1.14 (3H, s, H-27), 1.32±2.13
(17H, m, H-5, 6, 7, 9, 11a, 15, 16, 19, 21, 22), 2.85
(1H, br d, J = 11.0 Hz, H-18), 3.47 (1H, d, J = 9.5 Hz,
H-1), 3.51 (1H, d, J = 12.0 Hz, H-24a), 3.66 (3H, s,
17-COOMe), 3.70 (2H, m, H-2 and H-24b), 3.97 (1H,
br s, H-3), 5.28 (1H, br s, H-12).
(
(
3H, d, J = 11.6 Hz, H-30), 1.09 (3H, s, H-23), 1.13
3H, s, H-27), 1.20±2.02 (17H, m, H-5, 6, 7, 9, 11a, 15,
16, 19, 20, 21, 22), 3.47 (1H, d, J = 9.5 Hz, H-1), 3.51
(
1H, d, J = 12.0 Hz, H-24a), 3.66 (3H, s, 17-COOMe),
3
5
.70 (2H, m, H-24b and H-2), 3.97 (1H, br s, H-3),
.25 (1H, br s, H-12).
3.8. Acetylation of compound 1a
3.11. Acetylation of compound 2a
Compound 1a (1.0 mg) was treated with 1 ml of
Ac O±pyridine (1:1). The reaction mixture was kept
Compound 2a (0.8 mg) was acetylated by the same
method as that for 1a to give a tetra-acetate 2b.
2
31
for 36 h at room temp. The solution was treated as
usually and the organic fraction was concentrated to
[a] +25.08 (MeOH; c 0.07); EIMS (probe) 70 eV, m/z
D
+
(rel. int.): 686 [M] (7), 627 (77), 626 (100), 566 (71),
3
1
1
506 (68), 262 (45), 203 (53); H NMR (300 MHz,
give a tetra-acetate (1b). [a] +27.08 (MeOH; c 0.06);
D
+
EIMS (probe) 70 eV, m/z (rel. int.): 686 [M] (3), 627
CDCl ): d 0.72 (3H, s, H-26), 0.88 (3H, s, H-29), 0.90
3
(
60), 626 (100), 566 (58), 506 (62), 262 (39), 203 (51);
H NMR (300 MHz, CDCl ): d 0.71 (3H, s, H-25),
(6H, s, H-30 and H-25), 0.93 (3H, s, H-23), 0.95 (3H,
s, H-27), 1.25±1.78 (18H, m, H-5, 6, 7, 9, 11, 15, 16,
1
3